DOI QR코드

DOI QR Code

Relationship between plasma asymmetric dimethylarginine and nitric oxide levels afects aerobic exercise training-induced reduction of arterial stifness in middle-aged and older adults

  • Shimomura, Mio (Faculty of Sport and Health Science, Ritsumeikan University) ;
  • Fujie, Shumpei (Faculty of Sport and Health Science, Ritsumeikan University) ;
  • Sanada, Kiyoshi (Faculty of Sport and Health Science, Ritsumeikan University) ;
  • Kajimoto, Hiroki (Faculty of Sport and Health Science, Ritsumeikan University) ;
  • Hamaoka, Takafumi (Sports Medicine for Health Promotion, Tokyo Medical University) ;
  • Iemitsu, Motoyuki (Faculty of Sport and Health Science, Ritsumeikan University)
  • Received : 2021.01.29
  • Accepted : 2021.03.11
  • Published : 2021.03.31

Abstract

[Purpose] Aerobic exercise training (AT) reverses aging-induced deterioration of arterial stiffness via increased arterial nitric oxide (NO) production. Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, was decreased by AT. However, whether AT-induced changes in ADMA levels are related to changes in nitrite/nitrate (NOx) levels remains unclear. Accordingly, we aimed to clarify whether the relationship between plasma ADMA and NOx levels afected the AT-induced reduction of arterial stifness in middle-aged and older adults. [Methods] Thirty-one healthy middle-aged and older male and female subjects (66.4 ± 1.3 years) were randomly divided into two groups: exercise intervention and sedentary controls. Subjects in the training group completed an 8-week AT (60%-70% peak oxygen uptake [${\dot{V}}O_{2peak}$] for 45 min, 3 days/week). [Results] AT signifcantly increased ${\dot{V}}O_{2peak}$ (P < 0.05) and decreased carotid β-stifness (P < 0.01). Moreover, plasma ADMA levels were significantly decreased while plasma NOx levels and NOx/ADMA ratio were significantly increased by AT (P < 0.01). Additionally, no sex diferences in AT-induced changes of circulating ADMA and NOx levels, NOx/ADMA ratio, and carotid β-stifness were observed. Furthermore, the AT-induced increase in circulating ADMA levels was negatively correlated with an increase in circulating NOx levels (r = -0.414, P < 0.05), and the AT-induced increase in NOx/ADMA ratio was negatively correlated with a decrease in carotid β-stifness (r = -0.514, P < 0.01). [Conclusion] These results suggest that the increase in circulating NOx with reduction of ADMA elicited by AT is associated with a decrease in arterial stiffness regardless of sex in middle-aged and older adults.

Keywords

Acknowledgement

The authors declare no conflicts of interest. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (#19K22828, M. Iemitsu).

References

  1. Vaitkevicius PV, Fleg JL, Engel JH, O'Connor FC, Wright JG, Lakatta LE, Yin FC, Lakatta EG. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993;88:1456-62. https://doi.org/10.1161/01.CIR.88.4.1456
  2. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol. 1994;140:669-82. https://doi.org/10.1093/oxfordjournals.aje.a117315
  3. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111-7. https://doi.org/10.1161/01.hyp.33.5.1111
  4. Laurent S, Boutouyrie P, Asmar R, I Gautier, B Laloux, L Guize, P Ducimetiere, A Benetos. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-41. https://doi.org/10.1161/01.hyp.37.5.1236
  5. Rowe JW. Clinical consequences of age-related impairments in vascular compliance. Am J Cardiol. 1987;60:68G-71G. https://doi.org/10.1016/0002-9149(87)90594-7
  6. Mohiaddin RH, Underwood SR, Bogren HG, Firmin DN, Klipstein RH, Rees RS, Longmore DB. Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br Heart J. 1989;62:90-6. https://doi.org/10.1136/hrt.62.2.90
  7. Tanaka H, DeSouza CA, Seals DR. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol. 1998;18:127-32. https://doi.org/10.1161/01.ATV.18.1.127
  8. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation. 2000;102:1270-5. https://doi.org/10.1161/01.CIR.102.11.1270
  9. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006;15:265-79. https://doi.org/10.1016/j.niox.2006.03.011
  10. Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, Cunnington C, Tousoulis D, Pillai R, Ratnatunga C, Stefanadis C, Channon KM. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J. 2009;30:1142-50. https://doi.org/10.1093/eurheartj/ehp061
  11. Boger RH. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med. 2006;38:126-36. https://doi.org/10.1080/07853890500472151
  12. Antoniades C, Demosthenous M, Tousoulis D, Antonopoulos AS, Vlachopoulos C, Toutouza M, Marinou K, Bakogiannis C, Mavragani K, Lazaros G, Koumallos N, Triantafyllou C, Lymperiadis D, Koutsilieris M, Stefanadis C. Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis. Hypertension. 2011;58:93-8. https://doi.org/10.1161/hypertensionaha.110.168245
  13. Boger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation. 2009;119:1592-600. https://doi.org/10.1161/CIRCULATIONAHA.108.838268
  14. Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Munzel T. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res. 2005;97:e53-9.
  15. Kielstein JT, Bode-Boger SM, Frolich JC, Ritz E, Haller H, Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation. 2003;107:1891-5. https://doi.org/10.1161/01.CIR.0000060496.23144.A7
  16. Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Correlates of arterial stiffness in an ageing population: role of asymmetric dimethylarginine. Pharmacol Res. 2009;60:503-7. https://doi.org/10.1016/j.phrs.2009.06.006
  17. Tanabe T, Maeda S, Miyauchi T, Iemitsu M, Takanashi M, Irukayama-Tomobe Y, Yokota T, Ohmori H, Matsuda M. Exercise training improves ageing-induced decrease in eNOS expression of the aorta. Acta Physiol Scand. 2003;178:3-10. https://doi.org/10.1046/j.1365-201X.2003.01100.x
  18. Fujie S, Hasegawa N, Horii N, Inoue K, Uchida M, Iemitsu M. Effects of combined exercise training and Chlorella intake on vasorelaxation mediated by nitric oxide in aged mice. Appl Physiol Nutr Metab. In press.
  19. Fujie S, Hasegawa N, Sato K, Fujita S, Sanada K, Hamaoka T, Iemitsu M. Aerobic exercise training-induced changes in serum adropin level are associated with reduced arterial stiffness in middle-aged and older adults. Am J Physiol Heart Circ Physiol. 2015;309:H1642-7. https://doi.org/10.1152/ajpheart.00338.2015
  20. Gomes VA, Casella-Filho A, Chagas AC, Tanus-Santos JE. Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. Nitric Oxide. 2008;19:345-50. https://doi.org/10.1016/j.niox.2008.08.005
  21. Maeda S, Miyaki A, Kumagai H, Eto M, So R, Tanaka K, Ajisaka R. Lifestyle modifcation decreases arterial stiffness and plasma asymmetric dimethylarginine level in overweight and obese men. Coron Artery Dis. 2013;24:583-8. https://doi.org/10.1097/MCA.0b013e3283647a99
  22. Mittermayer F, Pleiner J, Krzyzanowska K, Wiesinger GF, Francesconi M, Wolzt M. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus. Wien Klin Wochenschr. 2005;117:816-20. https://doi.org/10.1007/s00508-005-0476-y
  23. Richter B, Niessner A, Penka M, Grdic M, Steiner S, Strasser B, Ziegler S, Zorn G, Maurer G, Simeon-Rudolf V, Wojta J, Huber K. Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events. Thromb Haemost. 2005;94:1306-11. https://doi.org/10.1160/TH05-06-1306
  24. Schlager O, Giurgea A, Schuhfried O, Seidinger D, Hammer A, Groger M, Fialka-Moser V, Gschwandtner M, Koppensteiner R, Steiner S. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial. Atherosclerosis. 2011;217:240-8. https://doi.org/10.1016/j.atherosclerosis.2011.03.018
  25. Tanahashi K, Akazawa N, Miyaki A, Choi Y, Ra SG, Matsubara T, Kumagai H, Oikawa S, Maeda S. Aerobic exercise training decreases plasma asymmetric dimethylarginine concentrations with increase in arterial compliance in postmenopausal women. Am J Hypertens. 2014;27:415-21. https://doi.org/10.1093/ajh/hpt217
  26. Nakamura A, Kajitani S, Sato K, Kanazawa M, Kondo M, Endo H, Nozaki E. Decline of popliteal artery flow-mediated dilation with aging and possible involvement of asymmetric dimethylarginine in healthy men. J Med Ultrason. 2019;46:503-11. https://doi.org/10.1007/s10396-019-00946-2
  27. Weinberger MH, Fineberg NS, Fineberg SE. Effects of age, race, gender, blood pressure, and estrogen on arterial compliance. Am J Hypertens. 2002;15:358-63. https://doi.org/10.1016/S0895-7061(02)02261-6
  28. Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol. 2001;37:153-6. https://doi.org/10.1016/S0735-1097(00)01054-8
  29. Kawano H, Tanaka H, Miyachi M. Resistance training and arterial compliance: keeping the benefts while minimizing the stiffening. J Hypertens. 2006;24:1753-9. https://doi.org/10.1097/01.hjh.0000242399.60838.14
  30. Cvetkovic TP, Stefanovic NZ, Velickovic-Radovanovic RM, Paunovic GJ, Djordjevic VM, Stojanovic DR, Stojanovic IR, Pavlovic DD. Sex differences in oxidative and nitrosative stress parameters in kidney transplant patients on tacrolimus-based immunosuppression. Int Urol Nephrol. 2014;46:1217-24. https://doi.org/10.1007/s11255-013-0577-x
  31. Ardigo D, Stuehlinger M, Franzini L, Valtuena S, Piatti PM, Pachinger O, Reaven GM, Zavaroni I. ADMA is independently related to fow-mediated vasodilation in subjects at low cardiovascular risk. Eur J Clin Investig. 2007;37:263-9. https://doi.org/10.1111/j.1365-2362.2007.01781.x
  32. Protopsaltis I, Foussas S, Angelidi A, Gritzapis A, Sergentanis TN, Matsagos S, Tzirogiannis K, Panoutsopoulos GI, Dimitriadis G, Raptis S, Melidonis A. Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals. Cardiovasc Diabetol. 2012;11:141. https://doi.org/10.1186/1475-2840-11-141
  33. Pope AJ, Karuppiah K, Cardounel AJ. Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production. Pharmacol Res. 2009; 60: 461-5. https://doi.org/10.1016/j.phrs.2009.07.016
  34. Chen Y, Xu X, Sheng M, Zhang X, Gu Q, Zheng Z. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy. Exp Eye Res. 2009;89:1028-34. https://doi.org/10.1016/j.exer.2009.09.004
  35. Chen X, Li H, Wang Z, Zhou Q, Chen S, Yang B, Yin D, He H, He M. Quercetin protects the vascular endothelium against iron overload damages via ROS/ADMA/DDAHII/eNOS/NO pathway. Eur J Pharmacol. 2020;868:172885. https://doi.org/10.1016/j.ejphar.2019.172885